<div class="container">

<table style="width: 100%;"><tr>
<td>bmt</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Bone marrow transplantation data
</h2>

<h3>Description</h3>

<p>This multi-center acute leukemia study consists of 137 patients with acute myelocytic leukemia (AML) or acute lymphoblastic leukemia (ALL) aged 7 to 52 from March 1, 1984 to June 30, 1989 at four institutions (Klein and Moeschberger, 2003). The failure time on study is defined at time (in days) to relapse or death.</p>


<h3>Usage</h3>

<pre><code class="language-R">data(bmt)</code></pre>


<h3>Format</h3>

<p>The variables represented in the data set are as follows:
</p>

<dl>
<dt><code>g</code></dt>
<dd>
<p>Disease group: 1 - All, 2 - AML Low Risk, 3 - AML High Risk.</p>
</dd>
<dt><code>T1</code></dt>
<dd>
<p>Time to death or on study time.</p>
</dd>
<dt><code>T2</code></dt>
<dd>
<p>Disease free survival time (time to relapse, death or end of study).</p>
</dd>
<dt><code>d1</code></dt>
<dd>
<p>Death indicator: 1 - Dead, 0 - Alive.</p>
</dd>
<dt><code>d2</code></dt>
<dd>
<p>Relapse indicator: 1 - Relapsed, 0 - Disease Free.</p>
</dd>
<dt><code>d3</code></dt>
<dd>
<p>Disease free survival indicator: 1 - Dead or Relapsed, 0 - Alive Disease Free.</p>
</dd>
<dt><code>TA</code></dt>
<dd>
<p>Time to Acute Graft-Versus-Host Disease.</p>
</dd>
<dt><code>da</code></dt>
<dd>
<p>Acute GVHD indicator: 1 - Developed Acute GVHD, 0 - Never Developed Acute GVHD.</p>
</dd>
<dt><code>TC</code></dt>
<dd>
<p>Time to Chronic Graft-Versus-Host Disease.</p>
</dd>
<dt><code>dc</code></dt>
<dd>
<p>Chronic GVHD Indicator: 1 - Developed Chronic GVHD, 0 - Never Developed Chronic GVHD.</p>
</dd>
<dt><code>TP</code></dt>
<dd>
<p>Time to return of platelets to normal levels.</p>
</dd>
<dt><code>dp</code></dt>
<dd>
<p>Platelet recovery indicator: 1 - platelets returned to normal, 0 - platelets never returned to normal.</p>
</dd>
<dt><code>Z1</code></dt>
<dd>
<p>Patient age in years.</p>
</dd>
<dt><code>Z2</code></dt>
<dd>
<p>Donor age in years.</p>
</dd>
<dt><code>Z3</code></dt>
<dd>
<p>Patient sex: 1 - Male, 0 - Female.</p>
</dd>
<dt><code>Z4</code></dt>
<dd>
<p>Doner sex: 1 - Male, 0 - Female.</p>
</dd>
<dt><code>Z5</code></dt>
<dd>
<p>Patient CMV status: 1 - CMV positive, 0 - CMV negative.</p>
</dd>
<dt><code>Z6</code></dt>
<dd>
<p>Donor CMV status: 1 - CMV positive, 0 - CMV negative.</p>
</dd>
<dt><code>Z7</code></dt>
<dd>
<p>Waiting time to transplant in days.</p>
</dd>
<dt><code>Z8</code></dt>
<dd>
<p>FAB: 1 - FAB Grade 4 or 5 and AML, 0 - otherwise.</p>
</dd>
<dt><code>Z9</code></dt>
<dd>
<p>Hospital: 1 - The Ohio State University, 2 - Alferd , 3 - St. Vincent, 4 - Hahnemann.</p>
</dd>
<dt><code>Z10</code></dt>
<dd>
<p>MTX: used as a Graft-Versus-Host-Prophylactic 1 - Yes, 0 - No.</p>
</dd>  
</dl>
<h3>References</h3>

<p>Klein, J. P. and Moeschberger, M. L. (2003) <em>Survival Analysis: Techniques for Censored and Truncated Data</em>. Springer, New York, 2nd edition.
</p>


</div>